Skip to main content
LFMD logo

LFMD · LifeMD, Inc.

Track LFMD — free
$3.45 -0.01 (-0.29%) At close · Aug 14
Market Cap
$166.29M
Shares
48.20M

LifeMD, Inc. Earnings Call Transcripts

Every quarterly earnings call for LifeMD, Inc. (LFMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-05
LifeMD, Inc. Q2 FY2026 Earnings Call
Revenue
$47.28M
▼ 3.5% YoY
Diluted EPS
$-0.16
Gross margin
88.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
LifeMD, Inc. Q1 FY2026 Earnings Call
Confident tone Pharmacy and insurance infrastructure Subscriber and revenue growth Weight management / GLP-1
Revenue
$50.16M
▼ 1.4% YoY
Diluted EPS
$-0.20
Gross margin
88.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-09
LifeMD, Inc. Q4 FY2025 Earnings Call
Confident tone Men's health (RexMD) Weight management / GLP-1 Pharmacy infrastructure
Revenue
$33.98M*
▲ 403.7% YoY
Gross margin
84.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-17
LifeMD, Inc. Q3 FY2025 Earnings Call
Confident tone Insurance reimbursement and customer acquisition costs 503-A compounding pharmacy and in-house fulfillment Weight management and GLP-1 pricing
Revenue
$60.17M
▲ 13% YoY
Gross margin
87.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
LifeMD, Inc. Q2 FY2025 Earnings Call
Positive tone Weight management program Telehealth revenue and adjusted EBITDA growth LifeMD+ membership and marketplace
Revenue
$49.02M
▼ 3.2% YoY
Diluted EPS
$-0.05
Gross margin
86.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
LifeMD, Inc. Q1 FY2025 Earnings Call
Confident tone Telehealth / Weight Management Growth Financial Performance & Profitability GLP-1 Partnerships (LillyDirect / NovoCare)
Revenue
$50.89M
▲ 15.3% YoY
Diluted EPS
$-0.02
Gross margin
84.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-10
LifeMD, Inc. Q4 FY2024 Earnings Call
Revenue
$6.75M*
▼ 85% YoY
Gross margin
-0.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
LifeMD, Inc. Q3 FY2024 Earnings Call
Confident tone Weight management / GLP-1 dynamics RexMD men's health growth Telehealth core business momentum
Revenue
$53.27M
▲ 38% YoY
Diluted EPS
$-0.13
Gross margin
90.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
LifeMD, Inc. Q2 FY2024 Earnings Call
Confident tone GLP-1 weight management growth Telehealth core business strength WorkSimpli challenges and divestiture plan
Revenue
$50.66M
▲ 40.9% YoY
Gross margin
90.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
LifeMD, Inc. Q1 FY2024 Earnings Call
Confident tone GLP-1 weight management growth RexMD brand expansion WorkSimpli subsidiary
Revenue
$44.14M
▲ 33.3% YoY
Gross margin
89.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
LifeMD, Inc. Q4 FY2023 Earnings Call
Revenue
$44.86M*
▲ 59.5% YoY
Gross margin
88.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
LifeMD, Inc. Q3 FY2023 Earnings Call
Revenue
$38.61M
▲ 22.9% YoY
Gross margin
87.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
LifeMD, Inc. Q2 FY2023 Earnings Call
Revenue
$35.95M
▲ 18% YoY
Gross margin
87.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
LifeMD, Inc. Q1 FY2023 Earnings Call
Revenue
$33.13M
▲ 14.1% YoY
Gross margin
87.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-09-30
LifeMD, Inc. Q3 FY2022 Earnings Call
Revenue
$31.41M
▲ 25.9% YoY
Gross margin
85.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
LifeMD, Inc. Q2 FY2022 Earnings Call
Revenue
$30.46M
▲ 36.5% YoY
Gross margin
84.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
LifeMD, Inc. Q1 FY2022 Earnings Call
Revenue
$29.04M
▲ 59.6% YoY
Gross margin
81.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-19
LifeMD, Inc. Q4 FY2021 Earnings Call
Revenue
$27.42M*
▲ 112.6% YoY
Gross margin
79.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
LifeMD, Inc. Q3 FY2021 Earnings Call
Revenue
$24.95M
▲ 126.7% YoY
Gross margin
79.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
LifeMD, Inc. Q2 FY2021 Earnings Call
Revenue
$22.31M
▲ 145.5% YoY
Gross margin
81.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
LifeMD, Inc. Q1 FY2021 Earnings Call
Revenue
$18.20M
▲ 322.7% YoY
Gross margin
82.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-19
LifeMD, Inc. Q4 FY2020 Earnings Call
Revenue
$12.89M*
▲ 226.9% YoY
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
LifeMD, Inc. Q3 FY2020 Earnings Call
Revenue
$11.01M
▲ 252% YoY
Gross margin
84.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
LifeMD, Inc. Q2 FY2020 Earnings Call
Revenue
$9.09M
▲ 236.9% YoY
Gross margin
81.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 earnings calls
Key facts CIK 948320 CUSIP 53216B104 13F (30d) 113 filings 110 filers Visit website Investor relations